Mosaicism for trisomy 21: a review.
Papavassiliou P, Charalsawadi C, Rafferty K, Jackson-Cook C.
Am J Med Genet A. 2015 Jan;167A(1):26-39. doi: 10.1002/ajmg.a.36861. Epub 2014 Nov 20.
Consequences of trisomy 21 for brain development in Down syndrome.
Russo ML, Sousa AMM, Bhattacharyya A.
Nat Rev Neurosci. 2024 Nov;25(11):740-755. doi: 10.1038/s41583-024-00866-2. Epub 2024 Oct 8.
Trisomy 21.
Pereira EM.
Pediatr Rev. 2024 Feb 1;45(2):116-117. doi: 10.1542/pir.2022-005887.
Down syndrome--genetic and nutritional aspects of accompanying disorders.
Mazurek D, Wyka J.
Rocz Panstw Zakl Hig. 2015;66(3):189-94.
Down Syndrome.
Bull MJ.
N Engl J Med. 2020 Jun 11;382(24):2344-2352. doi: 10.1056/NEJMra1706537.
Trisomy 21 syndrome: is there anything new?
Castiglia PT.
J Pediatr Health Care. 1998 Jan-Feb;12(1):35-7. doi: 10.1016/s0891-5245(98)90028-1.
Down's syndrome.
Roizen NJ, Patterson D.
Lancet. 2003 Apr 12;361(9365):1281-9. doi: 10.1016/S0140-6736(03)12987-X.
Endocrine manifestations of Down syndrome.
Whooten R, Schmitt J, Schwartz A.
Curr Opin Endocrinol Diabetes Obes. 2018 Feb;25(1):61-66. doi: 10.1097/MED.0000000000000382.
Lung disease manifestations in Down syndrome.
Danopoulos S, Deutsch GH, Dumortier C, Mariani TJ, Al Alam D.
Am J Physiol Lung Cell Mol Physiol. 2021 Nov 1;321(5):L892-L899. doi: 10.1152/ajplung.00434.2020. Epub 2021 Sep 1.
Multiorgan involvement and management in children with Down syndrome.
Lagan N, Huggard D, Mc Grane F, Leahy TR, Franklin O, Roche E, Webb D, O' Marcaigh A, Cox D, El-Khuffash A, Greally P, Balfe J, Molloy EJ.
Acta Paediatr. 2020 Jun;109(6):1096-1111. doi: 10.1111/apa.15153. Epub 2020 Jan 24.
